Welcoming new talent: Strengthening our mission through research and innovation

We are pleased to announce the continued growth of our science team with the recent appointments of two outstanding researchers.

Asen Ivanov, Research Associate, joins with a strong foundation in drug discovery and a passion for advancing antibody-based therapies. He brings hands-on expertise in antibody discovery and engineering and will strengthen our capacity for optimisation and screening of our lead molecues.

Matthew Pace, Bioinformatician, strengthens the team with his expertise in computational biology and infrastructure design to support early-stage drug discovery. Now focused on virology and immunology, his contributions will be pivotal in enhancing our analytical frameworks and accelerating progress across our genomics and data-driven initiatives.

These hires reflect our ongoing investment in talent and capability, ensuring we remain at the forefront of research excellence and operational impact. We look forward to the valuable contributions Asen and Matthew will bring to our mission of protecting the vulnerable from serious viral disease.